TuHURA Biosciences, Inc./NV (HURA) stock
HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.25−0.11 (-8.09%)
Close on Nov 20, 2026Market cap $79.66MP/E –Yield –
TuHURA Biosciences cash
Cash and short-term investments held at the end of each period.
TuHURA Biosciences's cash was $995.98K at Jun 30, 2026. For fiscal 2025 it was $3.62M, up 135.8% from the year before. Over ten years it grew 70.2% a year on average. The highest annual figure on record is $11.78M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.62M | +135.8% |
| FY2023 | Jun 30, 2023 | $1.54M | -87.0% |
| FY2022 | Jun 30, 2022 | $11.78M | +11.8% |
| FY2021 | Jun 30, 2021 | $10.54M | +340.5% |
| FY2020 | Jun 30, 2020 | $2.39M | -35.7% |
| FY2019 | Jun 30, 2019 | $3.72M | -37.7% |
| FY2018 | Jun 30, 2018 | $5.97M | -9.3% |
| FY2017 | Jun 30, 2017 | $6.59M | +7.0% |
| FY2016 | Jun 30, 2016 | $6.16M | +48.8% |
| FY2013 | Dec 31, 2013 | $4.14M | +23164.0% |
| FY2012 | Dec 31, 2012 | $17.78K | +18.4% |
| FY2011 | Dec 31, 2011 | $15.02K | -38.4% |
| FY2010 | Dec 31, 2010 | $24.38K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $995.98K | -88.3% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $6.30M | +1.3% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $3.62M | +135.8% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $2.70M | -11.4% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $8.51M | -40.3% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $6.22M | -12.2% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $1.54M | -87.0% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $3.05M | -65.6% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $14.25M | +1.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $7.09M | -63.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $11.78M | +11.8% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $8.84M | -43.8% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $14.06M | -18.0% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $19.34M | -14.4% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $10.54M | +340.5% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $15.72M | +216.1% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $17.16M | +170.3% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $22.60M | +180.4% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.39M | -35.7% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $4.97M | +131.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $6.35M | +71.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $8.06M | +107.5% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $3.72M | -37.7% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $2.15M | -74.7% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $3.70M | -66.4% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $3.88M | -70.5% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $5.97M | -9.3% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $8.51M | +305.0% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $11.02M | +222.5% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $13.16M | +174.1% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $6.59M | +7.0% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $2.10M | +124.1% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $3.42M | +74.6% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $4.80M | +71.1% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $6.16M | +48.8% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $937.36K | -81.9% |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $1.96M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $2.80M | – |
| Q4 FY2013CQ4 2013 | Dec 31, 2013 | $4.14M | – |
| Q3 FY2013CQ3 2013 | Sep 30, 2013 | $5.17M | – |
See a number that looks wrong?